Search

everythinglearnresearchcommunity

for

Search:↓

Ovarian Hyperthecosis caused hypersexuality in an older woman and was successfully treated with surgery.

After chemotherapy for early breast cancer, 33.4% of patients had long-term significant hair loss, with some hair regrowth over time, but treatments for hair loss were largely ineffective.

SARMs may be an effective treatment for a certain type of breast cancer by blocking cancer growth and spread.

Chemotherapy can harm kidneys in breast cancer patients.

Eribulin-based chemotherapy is more effective and has fewer side effects for advanced triple-negative breast cancer.

Long-term use of finasteride may cause breast cancer in men.

Some breast cancer treatments, like taxanes, can cause long-term hair loss.

A 73-year-old woman's unusual hair loss and growth led to the discovery of a rare condition causing too much testosterone, which improved after her ovaries were removed.

Chemotherapy worsens nutritional status in breast cancer patients, requiring targeted nutritional strategies.

Anastrozole can cause increased testosterone, leading to symptoms like hair growth and thinning.

Melanoma patients can learn to check their skin, early balding in men may indicate similar risks as PCOS in women, certain criteria can help predict skin cancer behavior, small skin cancer may not need extra therapy after surgery, and sterile gloves don't reduce infection in minor surgeries.

Estrogen-progestin contraception lowers ovarian, endometrial, and colon cancer risk but may raise breast and cervical cancer risk, helps with menstrual and acne issues, and new methods are as effective as pills. Metformin helps overweight women with PCOS and insulin resistance, and dopamine agonists treat prolactinomas.

Postmenopausal hyperandrogenism involves excess male hormones causing symptoms like hair growth and acne, and requires ruling out tumors and other disorders.

Patients prioritize quality of life, overall survival, and progression-free survival in treatment decisions for advanced breast cancer.

Early diagnosis and surgery can improve symptoms of ovarian hyperthecosis in postmenopausal women.

Premature ovarian insufficiency (POI) can harm women's sexual health, and they may benefit from hormone therapy and counseling.

Surgery successfully treated a hidden ovarian tumor causing hair loss and excess hair growth in a postmenopausal woman.

Removing both ovaries treated the woman's excess male hormone symptoms.

Over half of postmenopausal women experience hair loss, with severity increasing with age, time since menopause, and higher body mass index.

Fulvestrant is a well-tolerated new treatment for advanced breast cancer that may delay chemotherapy.

5-alpha reductase inhibitors don't increase breast cancer or benign breast disorder risk in women.

Flaxseed lignans may reduce breast cancer risk in women.

Nearly 70% of postmenopausal women in Saudi Arabia experience hair loss, often linked to early menopause, chronic diseases, family history, and stress.

Breast cancer patients often worry, lose weight, and cope by praying, meditating, or seeking support.

Further testing of paclitaxel poliglumex for this cancer treatment is not justified.

Progesterone may help trans women with breast development and health, but more research is needed.

Medicines for enlarged prostate may raise the risk of breast growth and tenderness but not breast cancer.

A transman experienced lasting virilization symptoms after stopping testosterone, which were resolved with estradiol treatment.